NEIRG
BIIB icon

New England Investment & Retirement Group’s Biogen BIIB Stock Holding History

New England Investment & Retirement Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed -$6K – 79
2020
Q1 		$6K Buy
+20
New +$6.07K ﹤0.01% 155

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

New England Investment & Retirement Group's BIIB Position: Q2 2020 in Review

New England Investment & Retirement Group sold out of Biogen (BIIB) in Q2 2020, closing a stake of 20 shares — an estimated $6K sold.

New England Investment & Retirement Group first reported a position in BIIB in Q1 2020 and held it in 1 quarter. The position peaked at $6K in Q1 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • New England Investment & Retirement Group reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • New England Investment & Retirement Group sold 20 Biogen shares in Q2 2020, an estimated $6K.
  • New England Investment & Retirement Group first reported a position in Biogen in Q1 2020 and held it in 1 quarter.
  • New England Investment & Retirement Group's Biogen position peaked at $6K in Q1 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on New England Investment & Retirement Group's 13F filing for Q2 2020, filed 3 Aug 2020.